nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—head and neck cancer	0.725	1	CbGaD
Betamethasone—Erythema facial—Hydroxyurea—head and neck cancer	0.0092	0.0539	CcSEcCtD
Betamethasone—PLA2G1B—exocrine gland—head and neck cancer	0.00563	0.124	CbGeAlD
Betamethasone—Skin atrophy—Hydroxyurea—head and neck cancer	0.00556	0.0326	CcSEcCtD
Betamethasone—Atrophy—Hydroxyurea—head and neck cancer	0.00515	0.0302	CcSEcCtD
Betamethasone—Telangiectasia—Fluorouracil—head and neck cancer	0.00513	0.0301	CcSEcCtD
Betamethasone—PLA2G1B—mouth—head and neck cancer	0.00421	0.0929	CbGeAlD
Betamethasone—Allergic contact dermatitis—Fluorouracil—head and neck cancer	0.00346	0.0203	CcSEcCtD
Betamethasone—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00282	0.0166	CcSEcCtD
Betamethasone—Peptic ulcer—Vinblastine—head and neck cancer	0.00276	0.0162	CcSEcCtD
Betamethasone—Photopsia—Docetaxel—head and neck cancer	0.00274	0.0161	CcSEcCtD
Betamethasone—Blepharitis—Hydroxyurea—head and neck cancer	0.00273	0.016	CcSEcCtD
Betamethasone—PLA2G1B—connective tissue—head and neck cancer	0.00258	0.0569	CbGeAlD
Betamethasone—Neuritis—Vinblastine—head and neck cancer	0.00247	0.0145	CcSEcCtD
Betamethasone—PLA2G1B—epithelium—head and neck cancer	0.00245	0.054	CbGeAlD
Betamethasone—Oesophageal ulcer—Docetaxel—head and neck cancer	0.00239	0.014	CcSEcCtD
Betamethasone—PTGS2—cartilage tissue—head and neck cancer	0.00238	0.0526	CbGeAlD
Betamethasone—Blister—Hydroxyurea—head and neck cancer	0.00233	0.0137	CcSEcCtD
Betamethasone—Extravasation—Vinblastine—head and neck cancer	0.00211	0.0124	CcSEcCtD
Betamethasone—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00203	0.0119	CcSEcCtD
Betamethasone—Blepharitis—Fluorouracil—head and neck cancer	0.00197	0.0115	CcSEcCtD
Betamethasone—Amenorrhoea—Hydroxyurea—head and neck cancer	0.00191	0.0112	CcSEcCtD
Betamethasone—Ulcer—Hydroxyurea—head and neck cancer	0.00178	0.0104	CcSEcCtD
Betamethasone—Blister—Fluorouracil—head and neck cancer	0.00168	0.00984	CcSEcCtD
Betamethasone—Skin exfoliation—Hydroxyurea—head and neck cancer	0.0016	0.0094	CcSEcCtD
Betamethasone—Menstruation irregular—Docetaxel—head and neck cancer	0.00158	0.00924	CcSEcCtD
Betamethasone—Necrosis—Fluorouracil—head and neck cancer	0.00154	0.00903	CcSEcCtD
Betamethasone—PLA2G1B—head—head and neck cancer	0.00152	0.0335	CbGeAlD
Betamethasone—Tingling sensation—Fluorouracil—head and neck cancer	0.0015	0.00882	CcSEcCtD
Betamethasone—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.0015	0.00877	CcSEcCtD
Betamethasone—Stinging—Fluorouracil—head and neck cancer	0.00149	0.00875	CcSEcCtD
Betamethasone—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00147	0.0086	CcSEcCtD
Betamethasone—NR3C2—parotid gland—head and neck cancer	0.00145	0.032	CbGeAlD
Betamethasone—NR3C2—saliva-secreting gland—head and neck cancer	0.00139	0.0307	CbGeAlD
Betamethasone—Extravasation—Fluorouracil—head and neck cancer	0.00139	0.00813	CcSEcCtD
Betamethasone—Embolism—Docetaxel—head and neck cancer	0.00136	0.00797	CcSEcCtD
Betamethasone—Herpes simplex—Fluorouracil—head and neck cancer	0.00131	0.00769	CcSEcCtD
Betamethasone—Leukocytosis—Fluorouracil—head and neck cancer	0.00129	0.00754	CcSEcCtD
Betamethasone—Ulcer—Fluorouracil—head and neck cancer	0.00128	0.0075	CcSEcCtD
Betamethasone—NR3C2—connective tissue—head and neck cancer	0.00128	0.0282	CbGeAlD
Betamethasone—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00128	0.00748	CcSEcCtD
Betamethasone—Dermatitis contact—Fluorouracil—head and neck cancer	0.00119	0.00701	CcSEcCtD
Betamethasone—PGR—connective tissue—head and neck cancer	0.00119	0.0262	CbGeAlD
Betamethasone—Neuritis—Docetaxel—head and neck cancer	0.00117	0.00685	CcSEcCtD
Betamethasone—Rash erythematous—Docetaxel—head and neck cancer	0.00114	0.00668	CcSEcCtD
Betamethasone—PGR—epithelium—head and neck cancer	0.00113	0.0249	CbGeAlD
Betamethasone—Necrosis—Docetaxel—head and neck cancer	0.00111	0.00652	CcSEcCtD
Betamethasone—Oesophagitis—Fluorouracil—head and neck cancer	0.0011	0.00648	CcSEcCtD
Betamethasone—NR3C2—trachea—head and neck cancer	0.00107	0.0237	CbGeAlD
Betamethasone—CYP19A1—connective tissue—head and neck cancer	0.00107	0.0236	CbGeAlD
Betamethasone—Euphoric mood—Fluorouracil—head and neck cancer	0.00104	0.00609	CcSEcCtD
Betamethasone—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00102	0.00596	CcSEcCtD
Betamethasone—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00101	0.00595	CcSEcCtD
Betamethasone—Neuropathy peripheral—Vinblastine—head and neck cancer	0.00101	0.00592	CcSEcCtD
Betamethasone—Myocardial infarction—Vinblastine—head and neck cancer	0.00101	0.00592	CcSEcCtD
Betamethasone—Extravasation—Docetaxel—head and neck cancer	0.001	0.00587	CcSEcCtD
Betamethasone—Amenorrhoea—Docetaxel—head and neck cancer	0.000993	0.00582	CcSEcCtD
Betamethasone—PTGS2—mouth—head and neck cancer	0.000967	0.0214	CbGeAlD
Betamethasone—Weight increased—Hydroxyurea—head and neck cancer	0.000959	0.00562	CcSEcCtD
Betamethasone—NR3C1—neck—head and neck cancer	0.000955	0.0211	CbGeAlD
Betamethasone—Haemoglobin—Vinblastine—head and neck cancer	0.00093	0.00545	CcSEcCtD
Betamethasone—Haemorrhage—Vinblastine—head and neck cancer	0.000925	0.00542	CcSEcCtD
Betamethasone—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000921	0.0054	CcSEcCtD
Betamethasone—Dermatitis bullous—Fluorouracil—head and neck cancer	0.000918	0.00539	CcSEcCtD
Betamethasone—Cardiac failure—Fluorouracil—head and neck cancer	0.000899	0.00527	CcSEcCtD
Betamethasone—Lethargy—Fluorouracil—head and neck cancer	0.000896	0.00525	CcSEcCtD
Betamethasone—Osteoarthritis—Fluorouracil—head and neck cancer	0.000878	0.00515	CcSEcCtD
Betamethasone—PGR—lymphoid tissue—head and neck cancer	0.000868	0.0192	CbGeAlD
Betamethasone—NR3C2—thyroid gland—head and neck cancer	0.000848	0.0187	CbGeAlD
Betamethasone—Haemoglobin—Hydroxyurea—head and neck cancer	0.000848	0.00497	CcSEcCtD
Betamethasone—Haemorrhage—Hydroxyurea—head and neck cancer	0.000844	0.00495	CcSEcCtD
Betamethasone—Hallucination—Hydroxyurea—head and neck cancer	0.000839	0.00492	CcSEcCtD
Betamethasone—Irritability—Fluorouracil—head and neck cancer	0.000838	0.00491	CcSEcCtD
Betamethasone—Cardiac arrest—Fluorouracil—head and neck cancer	0.000835	0.00489	CcSEcCtD
Betamethasone—Skin exfoliation—Docetaxel—head and neck cancer	0.000833	0.00489	CcSEcCtD
Betamethasone—Fluid retention—Docetaxel—head and neck cancer	0.000828	0.00486	CcSEcCtD
Betamethasone—Neuropathy—Docetaxel—head and neck cancer	0.000819	0.0048	CcSEcCtD
Betamethasone—Alopecia—Vinblastine—head and neck cancer	0.000817	0.00479	CcSEcCtD
Betamethasone—Dry skin—Fluorouracil—head and neck cancer	0.000804	0.00472	CcSEcCtD
Betamethasone—Oesophagitis—Docetaxel—head and neck cancer	0.000797	0.00468	CcSEcCtD
Betamethasone—PGR—thyroid gland—head and neck cancer	0.000788	0.0174	CbGeAlD
Betamethasone—NR3C1—parotid gland—head and neck cancer	0.000778	0.0172	CbGeAlD
Betamethasone—Pulmonary oedema—Docetaxel—head and neck cancer	0.000777	0.00456	CcSEcCtD
Betamethasone—Muscular weakness—Fluorouracil—head and neck cancer	0.000774	0.00454	CcSEcCtD
Betamethasone—Angiopathy—Hydroxyurea—head and neck cancer	0.000765	0.00449	CcSEcCtD
Betamethasone—NR3C2—head—head and neck cancer	0.000752	0.0166	CbGeAlD
Betamethasone—Ill-defined disorder—Vinblastine—head and neck cancer	0.000747	0.00438	CcSEcCtD
Betamethasone—Alopecia—Hydroxyurea—head and neck cancer	0.000745	0.00437	CcSEcCtD
Betamethasone—NR3C1—saliva-secreting gland—head and neck cancer	0.000745	0.0165	CbGeAlD
Betamethasone—Erythema—Hydroxyurea—head and neck cancer	0.000734	0.00431	CcSEcCtD
Betamethasone—Thrombophlebitis—Docetaxel—head and neck cancer	0.000732	0.00429	CcSEcCtD
Betamethasone—Malaise—Vinblastine—head and neck cancer	0.000726	0.00426	CcSEcCtD
Betamethasone—Vertigo—Vinblastine—head and neck cancer	0.000723	0.00424	CcSEcCtD
Betamethasone—CYP19A1—thyroid gland—head and neck cancer	0.000709	0.0157	CbGeAlD
Betamethasone—PGR—head—head and neck cancer	0.000699	0.0154	CbGeAlD
Betamethasone—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000699	0.0041	CcSEcCtD
Betamethasone—Convulsion—Vinblastine—head and neck cancer	0.000698	0.00409	CcSEcCtD
Betamethasone—Hypertension—Vinblastine—head and neck cancer	0.000695	0.00408	CcSEcCtD
Betamethasone—NR3C1—connective tissue—head and neck cancer	0.000685	0.0151	CbGeAlD
Betamethasone—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000681	0.004	CcSEcCtD
Betamethasone—Discomfort—Vinblastine—head and neck cancer	0.000677	0.00397	CcSEcCtD
Betamethasone—Visual disturbance—Docetaxel—head and neck cancer	0.000668	0.00392	CcSEcCtD
Betamethasone—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000667	0.00391	CcSEcCtD
Betamethasone—Myocardial infarction—Fluorouracil—head and neck cancer	0.000663	0.00389	CcSEcCtD
Betamethasone—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000663	0.00389	CcSEcCtD
Betamethasone—Dermatitis bullous—Docetaxel—head and neck cancer	0.000663	0.00389	CcSEcCtD
Betamethasone—Malaise—Hydroxyurea—head and neck cancer	0.000662	0.00388	CcSEcCtD
Betamethasone—Conjunctivitis—Fluorouracil—head and neck cancer	0.000657	0.00386	CcSEcCtD
Betamethasone—NR3C1—epithelium—head and neck cancer	0.00065	0.0144	CbGeAlD
Betamethasone—Cardiac failure—Docetaxel—head and neck cancer	0.000649	0.00381	CcSEcCtD
Betamethasone—Lethargy—Docetaxel—head and neck cancer	0.000646	0.00379	CcSEcCtD
Betamethasone—Thrombocytopenia—Vinblastine—head and neck cancer	0.000643	0.00377	CcSEcCtD
Betamethasone—Convulsion—Hydroxyurea—head and neck cancer	0.000636	0.00373	CcSEcCtD
Betamethasone—CYP19A1—head—head and neck cancer	0.000629	0.0139	CbGeAlD
Betamethasone—Anorexia—Vinblastine—head and neck cancer	0.000626	0.00367	CcSEcCtD
Betamethasone—Migraine—Docetaxel—head and neck cancer	0.000624	0.00366	CcSEcCtD
Betamethasone—Discomfort—Hydroxyurea—head and neck cancer	0.000618	0.00362	CcSEcCtD
Betamethasone—Haemoglobin—Fluorouracil—head and neck cancer	0.00061	0.00358	CcSEcCtD
Betamethasone—Haemorrhage—Fluorouracil—head and neck cancer	0.000607	0.00356	CcSEcCtD
Betamethasone—Oedema—Hydroxyurea—head and neck cancer	0.000599	0.00351	CcSEcCtD
Betamethasone—Infection—Hydroxyurea—head and neck cancer	0.000595	0.00349	CcSEcCtD
Betamethasone—PTGS2—connective tissue—head and neck cancer	0.000593	0.0131	CbGeAlD
Betamethasone—Paraesthesia—Vinblastine—head and neck cancer	0.00059	0.00346	CcSEcCtD
Betamethasone—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000588	0.00345	CcSEcCtD
Betamethasone—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000587	0.00344	CcSEcCtD
Betamethasone—Dry skin—Docetaxel—head and neck cancer	0.000581	0.00341	CcSEcCtD
Betamethasone—NR3C1—trachea—head and neck cancer	0.000575	0.0127	CbGeAlD
Betamethasone—Anorexia—Hydroxyurea—head and neck cancer	0.000571	0.00335	CcSEcCtD
Betamethasone—Decreased appetite—Vinblastine—head and neck cancer	0.000571	0.00335	CcSEcCtD
Betamethasone—PTGS2—epithelium—head and neck cancer	0.000563	0.0124	CbGeAlD
Betamethasone—Pain—Vinblastine—head and neck cancer	0.000562	0.0033	CcSEcCtD
Betamethasone—Arrhythmia—Fluorouracil—head and neck cancer	0.000542	0.00318	CcSEcCtD
Betamethasone—Feeling abnormal—Vinblastine—head and neck cancer	0.000542	0.00318	CcSEcCtD
Betamethasone—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000537	0.00315	CcSEcCtD
Betamethasone—Alopecia—Fluorouracil—head and neck cancer	0.000537	0.00315	CcSEcCtD
Betamethasone—Erythema—Fluorouracil—head and neck cancer	0.000529	0.0031	CcSEcCtD
Betamethasone—Dyspepsia—Hydroxyurea—head and neck cancer	0.000528	0.00309	CcSEcCtD
Betamethasone—NR3C2—lymph node—head and neck cancer	0.000527	0.0116	CbGeAlD
Betamethasone—Decreased appetite—Hydroxyurea—head and neck cancer	0.000521	0.00306	CcSEcCtD
Betamethasone—Abdominal pain—Vinblastine—head and neck cancer	0.000519	0.00305	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000517	0.00303	CcSEcCtD
Betamethasone—Fatigue—Hydroxyurea—head and neck cancer	0.000517	0.00303	CcSEcCtD
Betamethasone—Pain—Hydroxyurea—head and neck cancer	0.000512	0.00301	CcSEcCtD
Betamethasone—NR3C1—lymphoid tissue—head and neck cancer	0.000501	0.0111	CbGeAlD
Betamethasone—Weight increased—Docetaxel—head and neck cancer	0.000498	0.00292	CcSEcCtD
Betamethasone—PTGS2—trachea—head and neck cancer	0.000498	0.011	CbGeAlD
Betamethasone—Weight decreased—Docetaxel—head and neck cancer	0.000495	0.0029	CcSEcCtD
Betamethasone—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000494	0.0029	CcSEcCtD
Betamethasone—PGR—lymph node—head and neck cancer	0.00049	0.0108	CbGeAlD
Betamethasone—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000481	0.00282	CcSEcCtD
Betamethasone—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000479	0.00281	CcSEcCtD
Betamethasone—Myocardial infarction—Docetaxel—head and neck cancer	0.000479	0.00281	CcSEcCtD
Betamethasone—Conjunctivitis—Docetaxel—head and neck cancer	0.000475	0.00278	CcSEcCtD
Betamethasone—Body temperature increased—Hydroxyurea—head and neck cancer	0.000474	0.00278	CcSEcCtD
Betamethasone—Asthenia—Vinblastine—head and neck cancer	0.000471	0.00277	CcSEcCtD
Betamethasone—Convulsion—Fluorouracil—head and neck cancer	0.000458	0.00269	CcSEcCtD
Betamethasone—NR3C1—thyroid gland—head and neck cancer	0.000455	0.01	CbGeAlD
Betamethasone—Clobetasol propionate—CYP1A1—head and neck cancer	0.000451	0.476	CrCbGaD
Betamethasone—Myalgia—Fluorouracil—head and neck cancer	0.00045	0.00264	CcSEcCtD
Betamethasone—Diarrhoea—Vinblastine—head and neck cancer	0.00045	0.00264	CcSEcCtD
Betamethasone—Discomfort—Fluorouracil—head and neck cancer	0.000445	0.00261	CcSEcCtD
Betamethasone—CYP19A1—lymph node—head and neck cancer	0.000441	0.00973	CbGeAlD
Betamethasone—Haemoglobin—Docetaxel—head and neck cancer	0.00044	0.00258	CcSEcCtD
Betamethasone—Haemorrhage—Docetaxel—head and neck cancer	0.000438	0.00257	CcSEcCtD
Betamethasone—Dizziness—Vinblastine—head and neck cancer	0.000435	0.00255	CcSEcCtD
Betamethasone—PTGS2—lymphoid tissue—head and neck cancer	0.000433	0.00957	CbGeAlD
Betamethasone—Oedema—Fluorouracil—head and neck cancer	0.000431	0.00253	CcSEcCtD
Betamethasone—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000431	0.00253	CcSEcCtD
Betamethasone—Asthenia—Hydroxyurea—head and neck cancer	0.00043	0.00252	CcSEcCtD
Betamethasone—Infection—Fluorouracil—head and neck cancer	0.000429	0.00251	CcSEcCtD
Betamethasone—NR3C1—Adipogenesis—STAT6—head and neck cancer	0.000428	0.00736	CbGpPWpGaD
Betamethasone—Nervous system disorder—Fluorouracil—head and neck cancer	0.000423	0.00248	CcSEcCtD
Betamethasone—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000422	0.00248	CcSEcCtD
Betamethasone—Visual impairment—Docetaxel—head and neck cancer	0.000422	0.00248	CcSEcCtD
Betamethasone—Tachycardia—Fluorouracil—head and neck cancer	0.000421	0.00247	CcSEcCtD
Betamethasone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—head and neck cancer	0.000418	0.0072	CbGpPWpGaD
Betamethasone—Vomiting—Vinblastine—head and neck cancer	0.000418	0.00245	CcSEcCtD
Betamethasone—CYP19A1—Biological oxidations—NAT2—head and neck cancer	0.000412	0.0071	CbGpPWpGaD
Betamethasone—Headache—Vinblastine—head and neck cancer	0.000412	0.00241	CcSEcCtD
Betamethasone—Anorexia—Fluorouracil—head and neck cancer	0.000411	0.00241	CcSEcCtD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—HRAS—head and neck cancer	0.00041	0.00706	CbGpPWpGaD
Betamethasone—Diarrhoea—Hydroxyurea—head and neck cancer	0.00041	0.0024	CcSEcCtD
Betamethasone—Eye disorder—Docetaxel—head and neck cancer	0.00041	0.0024	CcSEcCtD
Betamethasone—CYP19A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000407	0.007	CbGpPWpGaD
Betamethasone—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—head and neck cancer	0.000404	0.00696	CbGpPWpGaD
Betamethasone—NR3C1—head—head and neck cancer	0.000403	0.00891	CbGeAlD
Betamethasone—Hypotension—Fluorouracil—head and neck cancer	0.000403	0.00236	CcSEcCtD
Betamethasone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000403	0.00693	CbGpPWpGaD
Betamethasone—Angiopathy—Docetaxel—head and neck cancer	0.000398	0.00233	CcSEcCtD
Betamethasone—Dizziness—Hydroxyurea—head and neck cancer	0.000396	0.00232	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000393	0.0023	CcSEcCtD
Betamethasone—NR3C2—Generic Transcription Pathway—YAP1—head and neck cancer	0.000393	0.00676	CbGpPWpGaD
Betamethasone—Arrhythmia—Docetaxel—head and neck cancer	0.000391	0.0023	CcSEcCtD
Betamethasone—Nausea—Vinblastine—head and neck cancer	0.00039	0.00229	CcSEcCtD
Betamethasone—Insomnia—Fluorouracil—head and neck cancer	0.00039	0.00229	CcSEcCtD
Betamethasone—Paraesthesia—Fluorouracil—head and neck cancer	0.000387	0.00227	CcSEcCtD
Betamethasone—Alopecia—Docetaxel—head and neck cancer	0.000387	0.00227	CcSEcCtD
Betamethasone—Erythema—Docetaxel—head and neck cancer	0.000381	0.00224	CcSEcCtD
Betamethasone—Vomiting—Hydroxyurea—head and neck cancer	0.000381	0.00223	CcSEcCtD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—RAD51—head and neck cancer	0.000381	0.00656	CbGpPWpGaD
Betamethasone—Dyspepsia—Fluorouracil—head and neck cancer	0.00038	0.00223	CcSEcCtD
Betamethasone—Rash—Hydroxyurea—head and neck cancer	0.000378	0.00222	CcSEcCtD
Betamethasone—Dermatitis—Hydroxyurea—head and neck cancer	0.000378	0.00221	CcSEcCtD
Betamethasone—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000377	0.00649	CbGpPWpGaD
Betamethasone—CYP19A1—FSH signaling pathway—MAPK3—head and neck cancer	0.000376	0.00648	CbGpPWpGaD
Betamethasone—Headache—Hydroxyurea—head and neck cancer	0.000375	0.0022	CcSEcCtD
Betamethasone—Decreased appetite—Fluorouracil—head and neck cancer	0.000375	0.0022	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000372	0.00218	CcSEcCtD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000371	0.00638	CbGpPWpGaD
Betamethasone—Pain—Fluorouracil—head and neck cancer	0.000369	0.00216	CcSEcCtD
Betamethasone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000364	0.00626	CbGpPWpGaD
Betamethasone—PLA2G1B—Fc-epsilon receptor I signaling in mast cells—AKT1—head and neck cancer	0.000362	0.00624	CbGpPWpGaD
Betamethasone—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000362	0.00623	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000361	0.00621	CbGpPWpGaD
Betamethasone—CYP19A1—FSH signaling pathway—MAPK1—head and neck cancer	0.000358	0.00617	CbGpPWpGaD
Betamethasone—Nausea—Hydroxyurea—head and neck cancer	0.000356	0.00209	CcSEcCtD
Betamethasone—Feeling abnormal—Fluorouracil—head and neck cancer	0.000355	0.00208	CcSEcCtD
Betamethasone—PTGS2—S1P1 pathway—VEGFA—head and neck cancer	0.000352	0.00606	CbGpPWpGaD
Betamethasone—PTGS2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.00035	0.00603	CbGpPWpGaD
Betamethasone—PTGS2—head—head and neck cancer	0.000349	0.00771	CbGeAlD
Betamethasone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—head and neck cancer	0.000349	0.00601	CbGpPWpGaD
Betamethasone—ABCB1—epithelium—head and neck cancer	0.000348	0.00768	CbGeAlD
Betamethasone—PTGS2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000347	0.00597	CbGpPWpGaD
Betamethasone—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000343	0.0059	CbGpPWpGaD
Betamethasone—Urticaria—Fluorouracil—head and neck cancer	0.000343	0.00201	CcSEcCtD
Betamethasone—Syncope—Docetaxel—head and neck cancer	0.000342	0.00201	CcSEcCtD
Betamethasone—Body temperature increased—Fluorouracil—head and neck cancer	0.000341	0.002	CcSEcCtD
Betamethasone—Loss of consciousness—Docetaxel—head and neck cancer	0.000335	0.00197	CcSEcCtD
Betamethasone—PTGS2—S1P1 pathway—MAPK3—head and neck cancer	0.000333	0.00574	CbGpPWpGaD
Betamethasone—Convulsion—Docetaxel—head and neck cancer	0.000331	0.00194	CcSEcCtD
Betamethasone—Hypertension—Docetaxel—head and neck cancer	0.000329	0.00193	CcSEcCtD
Betamethasone—PLA2G1B—Phospholipid metabolism—PTEN—head and neck cancer	0.000327	0.00563	CbGpPWpGaD
Betamethasone—Myalgia—Docetaxel—head and neck cancer	0.000325	0.0019	CcSEcCtD
Betamethasone—PTGS2—S1P1 pathway—MAPK1—head and neck cancer	0.000317	0.00546	CbGpPWpGaD
Betamethasone—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000315	0.00543	CbGpPWpGaD
Betamethasone—Oedema—Docetaxel—head and neck cancer	0.000311	0.00183	CcSEcCtD
Betamethasone—Anaphylactic shock—Docetaxel—head and neck cancer	0.000311	0.00183	CcSEcCtD
Betamethasone—Infection—Docetaxel—head and neck cancer	0.000309	0.00181	CcSEcCtD
Betamethasone—ABCB1—trachea—head and neck cancer	0.000308	0.00679	CbGeAlD
Betamethasone—Shock—Docetaxel—head and neck cancer	0.000306	0.0018	CcSEcCtD
Betamethasone—Nervous system disorder—Docetaxel—head and neck cancer	0.000305	0.00179	CcSEcCtD
Betamethasone—Pruritus—Fluorouracil—head and neck cancer	0.000305	0.00179	CcSEcCtD
Betamethasone—Thrombocytopenia—Docetaxel—head and neck cancer	0.000305	0.00179	CcSEcCtD
Betamethasone—Tachycardia—Docetaxel—head and neck cancer	0.000304	0.00178	CcSEcCtD
Betamethasone—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000303	0.00522	CbGpPWpGaD
Betamethasone—Anorexia—Docetaxel—head and neck cancer	0.000297	0.00174	CcSEcCtD
Betamethasone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—head and neck cancer	0.000295	0.00509	CbGpPWpGaD
Betamethasone—Diarrhoea—Fluorouracil—head and neck cancer	0.000295	0.00173	CcSEcCtD
Betamethasone—Hypotension—Docetaxel—head and neck cancer	0.000291	0.00171	CcSEcCtD
Betamethasone—NR3C1—Endoderm Differentiation—NOTCH1—head and neck cancer	0.000286	0.00493	CbGpPWpGaD
Betamethasone—Dizziness—Fluorouracil—head and neck cancer	0.000285	0.00167	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000284	0.00166	CcSEcCtD
Betamethasone—NR3C1—lymph node—head and neck cancer	0.000283	0.00624	CbGeAlD
Betamethasone—Insomnia—Docetaxel—head and neck cancer	0.000282	0.00165	CcSEcCtD
Betamethasone—Paraesthesia—Docetaxel—head and neck cancer	0.00028	0.00164	CcSEcCtD
Betamethasone—Vomiting—Fluorouracil—head and neck cancer	0.000274	0.00161	CcSEcCtD
Betamethasone—Dyspepsia—Docetaxel—head and neck cancer	0.000274	0.00161	CcSEcCtD
Betamethasone—Rash—Fluorouracil—head and neck cancer	0.000272	0.0016	CcSEcCtD
Betamethasone—Dermatitis—Fluorouracil—head and neck cancer	0.000272	0.00159	CcSEcCtD
Betamethasone—Decreased appetite—Docetaxel—head and neck cancer	0.000271	0.00159	CcSEcCtD
Betamethasone—Headache—Fluorouracil—head and neck cancer	0.00027	0.00158	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000269	0.00158	CcSEcCtD
Betamethasone—Fatigue—Docetaxel—head and neck cancer	0.000268	0.00157	CcSEcCtD
Betamethasone—ABCB1—lymphoid tissue—head and neck cancer	0.000268	0.00592	CbGeAlD
Betamethasone—Pain—Docetaxel—head and neck cancer	0.000266	0.00156	CcSEcCtD
Betamethasone—PGR—Generic Transcription Pathway—RARB—head and neck cancer	0.000263	0.00453	CbGpPWpGaD
Betamethasone—Feeling abnormal—Docetaxel—head and neck cancer	0.000257	0.0015	CcSEcCtD
Betamethasone—Nausea—Fluorouracil—head and neck cancer	0.000256	0.0015	CcSEcCtD
Betamethasone—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000255	0.00149	CcSEcCtD
Betamethasone—CYP19A1—FSH signaling pathway—AKT1—head and neck cancer	0.000254	0.00437	CbGpPWpGaD
Betamethasone—Body temperature increased—Docetaxel—head and neck cancer	0.000246	0.00144	CcSEcCtD
Betamethasone—Abdominal pain—Docetaxel—head and neck cancer	0.000246	0.00144	CcSEcCtD
Betamethasone—PTGS2—lymph node—head and neck cancer	0.000245	0.0054	CbGeAlD
Betamethasone—ABCB1—thyroid gland—head and neck cancer	0.000243	0.00537	CbGeAlD
Betamethasone—PTGS2—C-MYB transcription factor network—GSTM1—head and neck cancer	0.000241	0.00416	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—YAP1—head and neck cancer	0.000239	0.00412	CbGpPWpGaD
Betamethasone—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000234	0.00402	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000232	0.00399	CbGpPWpGaD
Betamethasone—PLA2G1B—Phospholipid metabolism—PIK3CA—head and neck cancer	0.000231	0.00397	CbGpPWpGaD
Betamethasone—Asthenia—Docetaxel—head and neck cancer	0.000223	0.00131	CcSEcCtD
Betamethasone—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000223	0.00384	CbGpPWpGaD
Betamethasone—Triamcinolone—PTGS2—head and neck cancer	0.000222	0.234	CrCbGaD
Betamethasone—Pruritus—Docetaxel—head and neck cancer	0.00022	0.00129	CcSEcCtD
Betamethasone—ABCB1—head—head and neck cancer	0.000216	0.00477	CbGeAlD
Betamethasone—Diarrhoea—Docetaxel—head and neck cancer	0.000213	0.00125	CcSEcCtD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000211	0.00363	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—RARB—head and neck cancer	0.000208	0.00358	CbGpPWpGaD
Betamethasone—Dizziness—Docetaxel—head and neck cancer	0.000206	0.00121	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000205	0.00353	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—GSTM1—head and neck cancer	0.000204	0.00351	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000203	0.0035	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—GSTM1—head and neck cancer	0.000201	0.00346	CbGpPWpGaD
Betamethasone—Vomiting—Docetaxel—head and neck cancer	0.000198	0.00116	CcSEcCtD
Betamethasone—Rash—Docetaxel—head and neck cancer	0.000196	0.00115	CcSEcCtD
Betamethasone—Dermatitis—Docetaxel—head and neck cancer	0.000196	0.00115	CcSEcCtD
Betamethasone—Headache—Docetaxel—head and neck cancer	0.000195	0.00114	CcSEcCtD
Betamethasone—PLA2G1B—Metabolism—NAT2—head and neck cancer	0.000193	0.00333	CbGpPWpGaD
Betamethasone—CYP19A1—Biological oxidations—CYP1A1—head and neck cancer	0.000193	0.00332	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—IL2—head and neck cancer	0.000193	0.00332	CbGpPWpGaD
Betamethasone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.000191	0.00329	CbGpPWpGaD
Betamethasone—CYP19A1—Metapathway biotransformation—CYP1A1—head and neck cancer	0.00019	0.00328	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—YAP1—head and neck cancer	0.000189	0.00325	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—CCND1—head and neck cancer	0.000188	0.00323	CbGpPWpGaD
Betamethasone—Nausea—Docetaxel—head and neck cancer	0.000185	0.00108	CcSEcCtD
Betamethasone—NR3C1—AP-1 transcription factor network—PTEN—head and neck cancer	0.000181	0.00312	CbGpPWpGaD
Betamethasone—NR3C2—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000177	0.00305	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000174	0.00299	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—UROD—head and neck cancer	0.00017	0.00292	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—IL2—head and neck cancer	0.00017	0.00292	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—DPYD—head and neck cancer	0.000169	0.00292	CbGpPWpGaD
Betamethasone—Dexamethasone—CYP1A1—head and neck cancer	0.000169	0.178	CrCbGaD
Betamethasone—PGR—Signaling by ERBB4—PTEN—head and neck cancer	0.000169	0.0029	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000164	0.00283	CbGpPWpGaD
Betamethasone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000163	0.00281	CbGpPWpGaD
Betamethasone—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000162	0.00279	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—YAP1—head and neck cancer	0.000161	0.00277	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CASP8—head and neck cancer	0.000156	0.00269	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000156	0.00269	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000156	0.00269	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CDH1—head and neck cancer	0.000154	0.00266	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—RARB—head and neck cancer	0.000152	0.00262	CbGpPWpGaD
Betamethasone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000151	0.00261	CbGpPWpGaD
Betamethasone—ABCB1—lymph node—head and neck cancer	0.000151	0.00334	CbGeAlD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000149	0.00257	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—MAPK3—head and neck cancer	0.000144	0.00248	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	0.000143	0.00247	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—YAP1—head and neck cancer	0.000138	0.00238	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—MAPK1—head and neck cancer	0.000137	0.00236	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—EGFR—head and neck cancer	0.000137	0.00236	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—head and neck cancer	0.000136	0.00235	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—BCL2—head and neck cancer	0.000134	0.00231	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000132	0.00227	CbGpPWpGaD
Betamethasone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000131	0.00225	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—head and neck cancer	0.00013	0.00224	CbGpPWpGaD
Betamethasone—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000129	0.00222	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000127	0.00218	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—RARB—head and neck cancer	0.000127	0.00218	CbGpPWpGaD
Betamethasone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000125	0.00216	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—CASP8—head and neck cancer	0.000124	0.00214	CbGpPWpGaD
Betamethasone—NR3C1—AP-1 transcription factor network—TP53—head and neck cancer	0.000124	0.00213	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	0.000123	0.00212	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000121	0.00208	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—NAT2—head and neck cancer	0.00012	0.00207	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000119	0.00205	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	0.000119	0.00204	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—CCND1—head and neck cancer	0.000115	0.00198	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—YAP1—head and neck cancer	0.000115	0.00198	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—UROD—head and neck cancer	0.000113	0.00195	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—PTEN—head and neck cancer	0.000111	0.00191	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—HRAS—head and neck cancer	0.00011	0.0019	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—TP53—head and neck cancer	0.000109	0.00188	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000108	0.00186	CbGpPWpGaD
Betamethasone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000106	0.00183	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KISS1—head and neck cancer	0.000106	0.00182	CbGpPWpGaD
Betamethasone—Dexamethasone—PTGS2—head and neck cancer	0.000106	0.111	CrCbGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000105	0.00181	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—head and neck cancer	0.0001	0.00173	CbGpPWpGaD
Betamethasone—NR3C1—Adipogenesis—STAT3—head and neck cancer	9.88e-05	0.0017	CbGpPWpGaD
Betamethasone—PGR—Signaling by ERBB4—AKT1—head and neck cancer	9.72e-05	0.00167	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—TYMS—head and neck cancer	9.65e-05	0.00166	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	9.61e-05	0.00166	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GSTM1—head and neck cancer	9.54e-05	0.00164	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—IL2—head and neck cancer	9.39e-05	0.00162	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	9.37e-05	0.00161	CbGpPWpGaD
Betamethasone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—head and neck cancer	9.29e-05	0.0016	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	9.22e-05	0.00159	CbGpPWpGaD
Betamethasone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—head and neck cancer	9.2e-05	0.00158	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—GPX1—head and neck cancer	9.13e-05	0.00157	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—CYP1A1—head and neck cancer	9.04e-05	0.00156	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—MAPK1—head and neck cancer	9.04e-05	0.00156	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—EGFR—head and neck cancer	9.03e-05	0.00156	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.02e-05	0.00155	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	8.98e-05	0.00155	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.81e-05	0.00152	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—GRP—head and neck cancer	8.71e-05	0.0015	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	8.66e-05	0.00149	CbGpPWpGaD
Betamethasone—NR3C1—SIDS Susceptibility Pathways—VEGFA—head and neck cancer	8.62e-05	0.00148	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—NOTCH1—head and neck cancer	8.52e-05	0.00147	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT6—head and neck cancer	8.46e-05	0.00146	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—UROD—head and neck cancer	8.05e-05	0.00139	CbGpPWpGaD
Betamethasone—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	7.98e-05	0.00137	CbGpPWpGaD
Betamethasone—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	7.75e-05	0.00133	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	7.73e-05	0.00133	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—TP53—head and neck cancer	7.58e-05	0.00131	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.49e-05	0.00129	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—YAP1—head and neck cancer	7.49e-05	0.00129	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.43e-05	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	7.43e-05	0.00128	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.41e-05	0.00128	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	7.35e-05	0.00127	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	7.35e-05	0.00127	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—RARB—head and neck cancer	7.31e-05	0.00126	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—NAT2—head and neck cancer	7.05e-05	0.00121	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—YAP1—head and neck cancer	6.65e-05	0.00115	CbGpPWpGaD
Betamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	6.41e-05	0.0011	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	6.38e-05	0.0011	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—NOTCH1—head and neck cancer	6.23e-05	0.00107	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—DPYD—head and neck cancer	6.18e-05	0.00106	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	6.17e-05	0.00106	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	6.15e-05	0.00106	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	6.14e-05	0.00106	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	5.94e-05	0.00102	CbGpPWpGaD
Betamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5.88e-05	0.00101	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—YAP1—head and neck cancer	5.87e-05	0.00101	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	5.86e-05	0.00101	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	5.64e-05	0.00097	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	5.56e-05	0.000957	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	5.56e-05	0.000957	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—head and neck cancer	5.38e-05	0.000926	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	5.27e-05	0.000907	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	5.26e-05	0.000905	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—NOTCH1—head and neck cancer	5.19e-05	0.000893	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.01e-05	0.000862	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	5e-05	0.000861	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	5e-05	0.000861	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	5e-05	0.000861	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—UROD—head and neck cancer	4.96e-05	0.000853	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.95e-05	0.000853	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAPK3—head and neck cancer	4.71e-05	0.000812	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—NAT2—head and neck cancer	4.71e-05	0.000811	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—head and neck cancer	4.69e-05	0.000808	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	4.52e-05	0.000778	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.41e-05	0.000759	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	4.36e-05	0.000751	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	4.34e-05	0.000747	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	4.2e-05	0.000723	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—DPYD—head and neck cancer	4.13e-05	0.000712	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	3.94e-05	0.000678	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—YAP1—head and neck cancer	3.92e-05	0.000675	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.85e-05	0.000662	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	3.73e-05	0.000642	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	3.55e-05	0.000611	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	3.55e-05	0.000611	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	3.55e-05	0.000611	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—TYMS—head and neck cancer	3.52e-05	0.000607	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—head and neck cancer	3.48e-05	0.0006	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—NOTCH1—head and neck cancer	3.37e-05	0.000581	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—NAT2—head and neck cancer	3.34e-05	0.000575	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GPX1—head and neck cancer	3.34e-05	0.000574	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—head and neck cancer	3.31e-05	0.00057	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1A1—head and neck cancer	3.3e-05	0.000569	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—AKT1—head and neck cancer	3.18e-05	0.000547	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	3.08e-05	0.00053	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—NOTCH1—head and neck cancer	3e-05	0.000516	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	2.98e-05	0.000513	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—DPYD—head and neck cancer	2.93e-05	0.000504	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—head and neck cancer	2.87e-05	0.000494	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—YAP1—head and neck cancer	2.78e-05	0.000479	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.71e-05	0.000467	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—AKT1—head and neck cancer	2.7e-05	0.000465	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.57e-05	0.000442	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.51e-05	0.000433	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—TYMS—head and neck cancer	2.35e-05	0.000405	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—head and neck cancer	2.33e-05	0.000401	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—head and neck cancer	2.32e-05	0.0004	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—head and neck cancer	2.26e-05	0.00039	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPX1—head and neck cancer	2.23e-05	0.000384	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A1—head and neck cancer	2.21e-05	0.00038	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—head and neck cancer	2.18e-05	0.000376	CbGpPWpGaD
Betamethasone—PTGS2—Disease—NOTCH1—head and neck cancer	2.11e-05	0.000363	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—NAT2—head and neck cancer	2.06e-05	0.000354	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—head and neck cancer	1.97e-05	0.00034	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—head and neck cancer	1.96e-05	0.000338	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—STAT3—head and neck cancer	1.95e-05	0.000336	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—AKT1—head and neck cancer	1.94e-05	0.000333	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—head and neck cancer	1.87e-05	0.000321	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.81e-05	0.000312	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—DPYD—head and neck cancer	1.8e-05	0.000311	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK1—head and neck cancer	1.78e-05	0.000306	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EGFR—head and neck cancer	1.78e-05	0.000306	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—YAP1—head and neck cancer	1.71e-05	0.000295	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—head and neck cancer	1.71e-05	0.000295	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—TYMS—head and neck cancer	1.67e-05	0.000287	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—head and neck cancer	1.66e-05	0.000286	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—head and neck cancer	1.65e-05	0.000284	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPX1—head and neck cancer	1.58e-05	0.000272	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A1—head and neck cancer	1.56e-05	0.000269	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—head and neck cancer	1.54e-05	0.000265	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—head and neck cancer	1.49e-05	0.000257	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HRAS—head and neck cancer	1.43e-05	0.000245	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—head and neck cancer	1.37e-05	0.000235	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—AKT1—head and neck cancer	1.26e-05	0.000217	CbGpPWpGaD
Betamethasone—PTGS2—Disease—STAT3—head and neck cancer	1.22e-05	0.00021	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—head and neck cancer	1.21e-05	0.000208	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—head and neck cancer	1.17e-05	0.000201	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—head and neck cancer	1.14e-05	0.000197	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—AKT1—head and neck cancer	1.12e-05	0.000193	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK1—head and neck cancer	1.11e-05	0.000191	CbGpPWpGaD
Betamethasone—PTGS2—Disease—EGFR—head and neck cancer	1.11e-05	0.000191	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—TYMS—head and neck cancer	1.03e-05	0.000177	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.02e-05	0.000175	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—AKT1—head and neck cancer	9.87e-06	0.00017	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPX1—head and neck cancer	9.73e-06	0.000168	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—head and neck cancer	9.64e-06	0.000166	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A1—head and neck cancer	9.64e-06	0.000166	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—head and neck cancer	9.3e-06	0.00016	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HRAS—head and neck cancer	8.92e-06	0.000154	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—head and neck cancer	8.11e-06	0.00014	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—head and neck cancer	8.07e-06	0.000139	CbGpPWpGaD
Betamethasone—PTGS2—Disease—AKT1—head and neck cancer	7.87e-06	0.000136	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—AKT1—head and neck cancer	6.6e-06	0.000114	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—head and neck cancer	5.73e-06	9.87e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—head and neck cancer	5.72e-06	9.85e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—head and neck cancer	5e-06	8.61e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—AKT1—head and neck cancer	4.68e-06	8.05e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—head and neck cancer	3.53e-06	6.07e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—AKT1—head and neck cancer	2.88e-06	4.96e-05	CbGpPWpGaD
